You are here: Home » Companies » News
Business Standard

US FDA completes audit of Dr Reddy's Srikakulum plant; stock rises

Shares of Dr.Redyy's closed at Rs 2,470.85 a unit, up by 0.36 per cent compared to the previous close, at BSE on Friday

Press Trust of India  |  New Delhi 

Dr Reddy's

Dr Reddy's said Friday the US drug regulator has completed the audit of its Srikakulum plant with zero observations.

"...the audit of our Formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh by the US FDA, has been completed today with zero observations," Dr Reddy's said in BSE filing.

Shares of Dr.Redyy's closed at Rs 2,470.85 a unit, up by 0.36 per cent compared to the previous close, at BSE on Friday.

First Published: Fri, November 16 2018. 23:00 IST
RECOMMENDED FOR YOU